American International Group, Inc. Age X Therapeutics, Inc. Transaction History

American International Group, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 12, 2020	SELL	$0.68 - $1.13 $8,763 - $14,563	-12,888 Closed	0 $0
Q1 2020 May 04, 2020	SELL	$0.78 - $1.95 $336 - $840	-431 Reduced 3.24%	12,888 $12,000
Q4 2019 Feb 05, 2020	SELL	$1.25 - $1.82 $140 - $203	-112 Reduced 0.83%	13,319 $24,000
Q3 2019 Nov 08, 2019	SELL	$1.96 - $3.38 $182 - $314	-93 Reduced 0.69%	13,431 $26,000
Q2 2019 Aug 13, 2019	BUY	$2.58 - $4.92 $19,775 - $37,711	7,665 Added 130.82%	13,524 $50,000
Q1 2019 May 06, 2019	SELL	$3.0 - $4.85 $108 - $174	-36 Reduced 0.61%	5,859 $24,000
Q4 2018 Feb 13, 2019	BUY	$2.49 - $5.5 $14,678 - $32,422	5,895 New	5,895 $18,000

Ticker AGE
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,945,100
Description
AgeX Therapeutics, Inc., a biotechnology company, focuses on the development and commercialization of novel therapeutics targeting human aging and degenerative diseases in the United States. The company's lead cell-based therapeutic candidates in development include AGEX-BAT1, a cell therapy product candidate for the treatment of various age-rel...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.